Review highlights stronger myopia control with combination therapy

Combination therapy may offer better control of myopia progression than single-treatment approaches, particularly for patients with rapidly progressing disease, according to a recent review. Researchers found that combining optical treatments with atropine generally slowed axial elongation more effectively than monotherapy while remaining well-tolerated with minimal reported adverse effects. Among the...